ACEhämmarerelaterat

ACEhämmarerelaterat refers to conditions or effects associated with the use of angiotensin-converting enzyme (ACE) inhibitors. ACE inhibitors are a class of medications primarily used to treat high blood pressure and heart failure. They work by blocking the action of the enzyme that converts angiotensin I to angiotensin II, a substance that narrows blood vessels and increases blood pressure.

The most common side effect of ACE inhibitors is a dry, persistent cough, which can affect a significant percentage of patients. This cough is thought to be due to the accumulation of bradykinin, a substance that is broken down by ACE. Other potential side effects can include dizziness, fatigue, and an increased risk of kidney problems, particularly in individuals with pre-existing kidney disease or those taking certain other medications. Rarely, ACE inhibitors can cause angioedema, a serious swelling of the face, lips, tongue, or throat, which requires immediate medical attention. Electrolyte imbalances, such as hyperkalemia (high potassium levels), can also occur.

The benefits of ACE inhibitors in managing cardiovascular conditions often outweigh the risks of these side effects. Healthcare providers monitor patients for adverse reactions and may adjust the dosage or switch to a different class of medication if side effects are problematic. Understanding ACEhämmarerelaterat is crucial for both patients and clinicians to ensure safe and effective treatment.